CYTOKINE & GROWTH FACTOR REVIEWS

Scope & Guideline

Connecting Scholars through Cutting-Edge Scientific Discourse

Introduction

Welcome to the CYTOKINE & GROWTH FACTOR REVIEWS information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of CYTOKINE & GROWTH FACTOR REVIEWS, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1359-6101
PublisherELSEVIER SCI LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1996 to 2024
AbbreviationCYTOKINE GROWTH F R / Cytokine Growth Factor Rev.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address125 London Wall, London EC2Y 5AS, ENGLAND

Aims and Scopes

The journal 'Cytokine & Growth Factor Reviews' focuses on the intricate roles that cytokines and growth factors play in various biological processes and diseases. It aims to foster understanding through comprehensive reviews that integrate findings from molecular biology, immunology, and therapeutic applications.
  1. Cytokine Biology:
    The journal investigates the diverse roles of cytokines in immune response modulation, inflammation, and cell signaling pathways, emphasizing their implications in health and disease.
  2. Growth Factor Signaling:
    Research covers the mechanisms by which growth factors influence cellular processes such as differentiation, proliferation, and survival, particularly in the context of cancer and tissue repair.
  3. Intercellular Communication:
    Exploring the mechanisms of intercellular communication mediated by cytokines and growth factors, including the roles of extracellular vesicles and their impact on tumor microenvironments.
  4. Therapeutic Applications:
    The journal highlights the therapeutic potential of targeting cytokine and growth factor pathways, particularly in cancer immunotherapy, autoimmune diseases, and chronic inflammatory conditions.
  5. Translational Research:
    It emphasizes the translation of basic research findings into clinical applications, providing insights into biomarker discovery and personalized medicine approaches.
Recent publications in 'Cytokine & Growth Factor Reviews' reveal several emerging trends that reflect the evolving landscape of cytokine and growth factor research.
  1. Cancer Immunotherapy:
    A significant increase in research related to cytokines and growth factors in cancer immunotherapy, highlighting the importance of immune modulation in enhancing treatment efficacy.
  2. Neuroinflammation and Neurological Disorders:
    Emerging interest in the role of cytokines in neuroinflammation, particularly concerning conditions like stroke and neurodegenerative diseases, showcases a growing recognition of their impact on neurological health.
  3. Extracellular Vesicles:
    Research focusing on extracellular vesicles as mediators of communication in tumor microenvironments and their role in immune regulation is gaining traction, indicating a shift towards understanding cell-to-cell interactions.
  4. Aging and Senescence:
    An increasing number of studies are addressing the implications of cytokines in aging and cellular senescence, emphasizing their roles in age-related diseases and potential therapeutic interventions.
  5. Metabolic Regulation:
    There is a rising trend in exploring the intersections between cytokine signaling, metabolism, and chronic diseases, reflecting a broader understanding of the systemic effects of cytokines.

Declining or Waning

While 'Cytokine & Growth Factor Reviews' has maintained a robust focus on various themes, certain areas have shown signs of declining interest based on recent publications.
  1. Traditional Immune Pathways:
    There has been a noticeable decrease in papers focusing on classical immune pathways that were previously predominant, suggesting a shift towards more complex and nuanced interactions involving cytokines and growth factors.
  2. Basic Cytokine Function Studies:
    Research centered solely on the basic functions of individual cytokines without considering their interactions or roles in disease contexts seems to be waning, reflecting a trend towards integrative approaches.
  3. Non-Inflammatory Roles of Cytokines:
    Themes exploring the non-inflammatory roles of cytokines, such as their effects on metabolic processes, appear less frequently, indicating a potential narrowing of focus within the journal.

Similar Journals

FEBS Journal

Advancing the Frontiers of Biochemical Research
Publisher: WILEYISSN: 1742-464XFrequency: 24 issues/year

FEBS Journal is a prestigious, peer-reviewed publication dedicated to advancing the field of biochemistry, cell biology, and molecular biology. Published by WILEY in the United Kingdom, this journal boasts an impressive impact factor and ranks in the top quartile (Q1) across multiple relevant categories, including Biochemistry, Cell Biology, and Molecular Biology, reflecting its significant contribution to scientific research. With an ISSN of 1742-464X and an E-ISSN of 1742-4658, the FEBS Journal publishes original research and comprehensive reviews that push the boundaries of knowledge and innovation in the biosciences. As a vital resource for researchers, professionals, and students alike, the journal offers Open Access options, ensuring that cutting-edge discoveries are accessible to a broad audience. With a publication history converging from 2005 to the present and a robust emphasis on high-quality scholarly work, the FEBS Journal remains an essential platform for the dissemination of significant findings and advancements in the life sciences.

PROTEIN AND PEPTIDE LETTERS

Pioneering pathways in therapeutic applications of proteins and peptides.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 0929-8665Frequency: 12 issues/year

PROTEIN AND PEPTIDE LETTERS is a prominent peer-reviewed journal published by Bentham Science Publishers Ltd, specializing in the dynamic fields of biochemistry and structural biology. With an ISSN of 0929-8665 and a corresponding E-ISSN of 1875-5305, the journal has been a pivotal platform for researchers since its inception in 1994. Spanning various aspects of protein and peptide research, it aims to disseminate groundbreaking findings that enhance our understanding of molecular mechanisms and therapeutic applications. Although categorized in the Q3 quartile for biochemistry and medicine, and Q4 in structural biology within the 2023 metrics, it remains a valuable resource in the academic arena, offering insight into the latest research and advancements. As the journal converges towards its 2024 milestone, it continues to reflect the evolving landscape of molecular research. While it currently does not offer open access, the accessibility to its impactful content is essential for students, professionals, and researchers invested in these critical scientific disciplines.

Cell Death & Disease

Bridging science and medicine for a healthier tomorrow.
Publisher: SPRINGERNATUREISSN: 2041-4889Frequency: 1 issue/year

Cell Death & Disease, published by SpringerNature, is a premier open-access journal dedicated to disseminating high-quality research on the mechanisms and implications of cell death, disease pathology, and therapeutic responses. Since its inception in 2010, the journal has quickly established itself within the top tier of academic publishing, achieving a notable impact factor and earning Q1 rankings in several critical categories including Cancer Research, Cell Biology, Cellular and Molecular Neuroscience, Immunology, and Medicine (miscellaneous). With its commitment to open access, Cell Death & Disease ensures that groundbreaking research is available to a global audience, fostering collaboration and advancing knowledge across disciplines. Residing at the forefront of crucial scientific discourse, this journal not only attracts submissions from leading researchers but also significantly influences the fields of molecular biology, immunology, and neurology. By bridging the gap between basic science and clinical applications, it provides vital insights for professionals, academicians, and students alike.

CANCER GENE THERAPY

Pioneering Research in Cancer Gene Therapy
Publisher: SPRINGERNATUREISSN: 0929-1903Frequency: 12 issues/year

Cancer Gene Therapy, published by SpringerNature, stands at the forefront of research in the fields of cancer research, molecular biology, and molecular medicine. With a robust impact factor reflecting its significant influence—ranking in the Q2 category for cancer research and Q1 for both molecular biology and molecular medicine—it serves as an essential resource for scholars and practitioners alike. Since its inception in 1994, the journal has dedicated itself to advancing the understanding and therapeutic application of genetic innovations in oncology. Notably, it holds distinguished Scopus ranks, placing it among the top tier journals in its categories, underscoring its importance to the scientific community. While open access options are not available, the compelling research published here offers invaluable insights into the latest advancements and strategies in cancer therapy. Engaging with *Cancer Gene Therapy* not only keeps professionals informed but also inspires future innovations in the quest for effective cancer treatments.

NATURE IMMUNOLOGY

Transforming research into real-world applications in immunology.
Publisher: NATURE PORTFOLIOISSN: 1529-2908Frequency: 12 issues/year

NATURE IMMUNOLOGY is a premier academic journal published by NATURE PORTFOLIO, dedicated to advancing the field of immunology. With an impressive impact factor that reflects its esteemed position, this journal ranks in the top quartile (Q1) of renowned categories, including Immunology and Allergy. Serving as a crucial platform for researchers, professionals, and students, NATURE IMMUNOLOGY showcases cutting-edge research, comprehensive reviews, and insightful perspectives that drive innovation in immunological science. Based in the United Kingdom, this journal has been a vital contributor to the global discourse on immune responses and related diseases since its inception in 2000. Researchers can benefit from its rigorous peer-review process, ensuring that only high-quality studies are disseminated, thus enhancing their academic pursuits and practical applications. Explore the latest findings and trends within this flourishing discipline, making NATURE IMMUNOLOGY an essential resource for anyone engaged in the study of the immune system.

CYTOKINE

Exploring the intricate roles of cytokines in health and disease.
Publisher: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTDISSN: 1043-4666Frequency: 12 issues/year

CYTOKINE is a prestigious peer-reviewed journal published by Academic Press Ltd - Elsevier Science Ltd, dedicated to advancing the field of immunology, biochemistry, and related biomedical sciences since its inception in 1989. With an ISSN of 1043-4666 and an E-ISSN of 1096-0023, this journal serves as a vital resource for researchers and professionals alike, offering cutting-edge research findings that delve into the roles and mechanisms of cytokines in health and disease. Recognized for its impactful contributions, CYTOKINE currently ranks in the Q2 quartile across several categories, including Biochemistry, Hematology, and Immunology, indicating its significant influence in these fields. Despite not offering open access, the journal maintains a high-quality standard, as evidenced by its robust Scopus rankings, including a notable 80th percentile in Medicine and Hematology. Researchers and students are encouraged to explore the latest findings and methodologies via CYTOKINE, as it continues to shape the future landscape of cytokine research and application.

CELL PROLIFERATION

Empowering Global Collaboration in Cell Biology
Publisher: WILEYISSN: 0960-7722Frequency: 12 issues/year

CELL PROLIFERATION, published by Wiley, is a leading open-access journal that has been at the forefront of research since its inception in 1968. With an impact factor that solidifies its position in the Q1 category of both Cell Biology and Medicine (Miscellaneous), this journal serves as a premier platform for disseminating groundbreaking studies in the field of cellular and molecular biology. The journal is renowned for its rigorous peer-review process and comprehensive coverage of topics related to cell growth, division, and differentiation, making it an invaluable resource for researchers, professionals, and students alike. With its notable Scopus ranking of #30 in Biochemistry, Genetics, and Molecular Biology: Cell Biology, and a robust open access model since 2019, CELL PROLIFERATION ensures that cutting-edge research is accessible to a global audience, fostering collaboration and innovation across the scientific community. Located in the United Kingdom, the journal remains committed to enhancing the understanding of cellular processes, thereby influencing developments in medicine and biotechnology.

CELLULAR & MOLECULAR BIOLOGY LETTERS

Transforming Knowledge in Biochemistry and Cell Biology
Publisher: BMCISSN: 1425-8153Frequency: 1 issue/year

CELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.

Cell Communication and Signaling

Illuminating the Pathways of Cellular Dialogue
Publisher: BMCISSN: Frequency: 1 issue/year

Cell Communication and Signaling is a premier peer-reviewed journal published by BMC that has made significant contributions to the fields of biochemistry, cell biology, and molecular biology since its establishment in 2003. As an open access journal, it offers unrestricted access to high-quality research, fostering collaboration and innovation among scientists around the globe. The journal is distinguished by its Q1 ranking in all three relevant categories for 2023, underscoring its critical role in advancing the understanding of cellular communication mechanisms and signaling pathways. Positioned within the United Kingdom, Cell Communication and Signaling has been an invaluable resource for researchers, professionals, and students alike, ensuring that the latest findings are accessible to a diverse range of audiences. With an impressive Scopus ranking—placing it in the top percentiles within its subject areas—this journal continues to set the standard for excellence in the pursuit of understanding complex cellular interactions.

CELL RESEARCH

Exploring Innovations in Molecular Biology
Publisher: SPRINGERNATUREISSN: 1001-0602Frequency: 12 issues/year

CELL RESEARCH is a premier peer-reviewed journal dedicated to advancing the field of cell biology and molecular biology, published by SpringerNature. With an impressive impact factor and consistently ranking in the Q1 quartile for both cell biology and molecular biology, this journal serves as a pivotal resource for researchers, professionals, and students seeking to explore the latest discoveries and advancements in cellular mechanisms and their implications for health and disease. Since its inception in 1996, CELL RESEARCH has cultivated a distinguished reputation, currently boasting ranks in the top percentile of Scopus categories, reaffirming its influence and relevance to the scientific community. Although it is not an Open Access journal, its rigorous selection process ensures the publication of high-quality articles that contribute significantly to our understanding of life sciences. For those deeply engaged in the realms of biochemistry, genetics, and molecular biology, CELL RESEARCH is an essential conduit of innovative research and critical insights.